These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21057848)

  • 1. Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.
    Tomino Y
    Clin Exp Nephrol; 2011 Feb; 15(1):1-7. PubMed ID: 21057848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy: lessons from an animal model, the ddY mouse.
    Tomino Y
    J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of prognosis in IgA nephropathy.
    Tomino Y
    Kaohsiung J Med Sci; 2012 Oct; 28(10):517-20. PubMed ID: 23089315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
    Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H
    Nephron; 1994; 66(1):81-6. PubMed ID: 7906404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of IgA nephropathy.
    Tomino Y
    Contrib Nephrol; 2007; 157():1-7. PubMed ID: 17495430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells.
    Suzuki H; Suzuki Y; Aizawa M; Yamanaka T; Kihara M; Pang H; Horikoshi S; Tomino Y
    Kidney Int; 2007 Aug; 72(3):319-27. PubMed ID: 17495863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Models of Human IgA Nephropathy.
    Suzuki H; Suzuki Y
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy. From molecules to men.
    Tomino Y
    Contrib Nephrol; 1999; 126():III-IX, 1-115. PubMed ID: 10489630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
    J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy.
    Imasawa T; Utsunomiya Y
    Exp Nephrol; 2002; 10(1):51-8. PubMed ID: 11803205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of monoclonal antibody CD4 on expression of intercellular adhesion molecule 1 in renal tissues of ddY mice: a spontaneous animal model of IgA nephropathy.
    Ohmuro H; Tomino Y; Koide H
    Am J Nephrol; 1994; 14(2):136-41. PubMed ID: 7915884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of monoclonal antibody CD4 on glomerulonephritis of ddY mice, a spontaneous animal model of IgA nephropathy.
    Tomino Y; Shimizu M; Koide H; Abe M; Shirai T
    Am J Kidney Dis; 1993 Apr; 21(4):427-32. PubMed ID: 8096678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathological predictors of prognosis in IgA nephropathy.
    Tomino Y
    Contrib Nephrol; 2013; 181():65-74. PubMed ID: 23689568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice.
    Liao J; Hayashi K; Horikoshi S; Ushijima H; Kimura J; Tomino Y
    Nephron; 2001 Oct; 89(2):194-200. PubMed ID: 11549902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.
    Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Takeda S; Takeda H; Hattori T
    Clin Exp Nephrol; 2010 Dec; 14(6):528-35. PubMed ID: 20814808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
    Sadakane C; Hattori T; Koseki J; Inagaki Y; Hasegawa Y; Shindo S; Takeda S; Takeda H
    Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.